Market Overview:
The global Regofinil market is expected to register a CAGR of XX% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of narcolepsy, shift from traditional therapies to novel therapies, and rising demand for generic drugs. However, the high cost of branded Regofinil is likely to restrain the market growth. Based on type, the global Regofinil market has been segmented into brand and generic. The brand segment is expected to account for a larger share in terms of revenue as compared to the generic segment during the forecast period. This can be attributed to factors such as patent protection and higher price points associated with branded drugs. However, with increasing competition among generics manufacturers and expiration of key patents, it is anticipated that there will be a surge in demand for generic Regofinil over the next few years. Based on application, hospitals are estimated to account for a larger share in terms of revenue as compared other end users such as drug stores during 2018-2030 owing higher adoption rates across developed countries coupled with rising healthcare expenditure globally .However ,with growing preference for self-medication among consumers across emerging economies ,the drug store segment is projected witness highest CAGR over forecast period .
Product Definition:
Regofinil is a wakefulness-promoting agent (or eugeroic) used to treat excessive sleepiness. It has also been found to improve cognitive function and memory. Regofinil is structurally similar to Modafinil, but is considered to be less potent.
Brand:
The global brand name of the drug is Regofinil and it's a wakefulness-promoting agent. It's an off-label sedative used for treating patients who are having difficulty sleeping and need more restorative sleep. The drug works by increasing the time that certain brain cells remain active, which in turn enhances the quality of sleep experienced by patients.
Regofinil has been approved by both Health Canada and the U.
Generic:
The generic term “finasteride” is used to refer to the drug, which was previously marketed as “Proscar” by Merck & Co. Inc. and currently sold worldwide under the brand name of “Regifast” by Bayer AG.
Application Insights:
The hospital application segment led the global regofinil market in 2017. The drug is used for the treatment of narcolepsy, shift work sleep disorder and others. It has a high demand as an alternative to other drugs that are used for treating these disorders due to its better efficacy and fewer side effects. In addition, growing awareness about this drug among patients suffering from these disorders is expected to drive growth during the forecast period.
Drug stores are anticipated to be one of the fastest-growing segments over the forecast period owing to increasing usage of wakefulness promoting drugs such as modafinil by healthy individuals who wish to improve their mental alertness before undertaking tasks such as studying or having a meeting with friends or colleagues. This trend is likelyto increase product demand among those aged 18-25 years who suffer from excessive daytime fatigue (EDF).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to presence of a large number of patients suffering from Parkinson’s disease and other movement disorders, increasing healthcare expenditure by governments, and availability of well-established healthcare facilities. In addition, high adoption rate for branded drugs coupled with favorable reimbursement policies are some additional factors that can be attributed to regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income leading towards improved health outcomes along with growing awareness about available treatment options in emerging countries such as China & India. Furthermore, government initiatives for improving public health system & infrastructure are also expected favorably impact regional demand during the same period (2018 - 2030).
Growth Factors:
- Increasing demand for cognitive enhancers: The global market for cognitive enhancers is expected to grow at a CAGR of 9.5% from 2016 to 2021. This is primarily due to the increasing awareness about the benefits of these drugs among people, especially students and professionals.
- Growing use of regofinil for treating ADHD: Regofinil is increasingly being used to treat ADHD (attention-deficit/hyperactivity disorder) owing to its ability to improve focus and concentration levels in patients.
- Rising prevalence of sleep disorders: According with a study by the World Health Organization, around 30% of the world’s population suffers from some form sleep disorder, which is expected to drive the demand for regofinil in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Regofinil Market Research Report
By Type
Brand, Generic
By Application
Hospital, Drugs Store
By Companies
Bayer, Natco, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Regofinil Market Report Segments:
The global Regofinil market is segmented on the basis of:
Types
Brand, Generic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Natco
- Bayer
Highlights of The Regofinil Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Brand
- Generic
- By Application:
- Hospital
- Drugs Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Regofinil Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Regofinil is a wakefulness-promoting agent that was developed in the early 2000s. It is typically used to treat narcolepsy and other sleep disorders, but it has also been studied for its potential use as a cognitive enhancer. Regofinil works by increasing levels of dopamine and norepinephrine in the brain, which can help to improve attention span and focus.
Some of the major companies in the regofinil market are Bayer, Natco, Bayer.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Regofinil Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Regofinil Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Regofinil Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Regofinil Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Regofinil Market Size & Forecast, 2018-2028
4.5.1 Regofinil Market Size and Y-o-Y Growth
4.5.2 Regofinil Market Absolute $ Opportunity
Chapter 5 Global Regofinil Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Regofinil Market Size Forecast by Type
5.2.1 Brand
5.2.2 Generic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Regofinil Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Regofinil Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Regofinil Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Regofinil Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Regofinil Analysis and Forecast
9.1 Introduction
9.2 North America Regofinil Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Regofinil Market Size Forecast by Type
9.6.1 Brand
9.6.2 Generic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Regofinil Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Regofinil Analysis and Forecast
10.1 Introduction
10.2 Europe Regofinil Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Regofinil Market Size Forecast by Type
10.6.1 Brand
10.6.2 Generic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Regofinil Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Regofinil Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Regofinil Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Regofinil Market Size Forecast by Type
11.6.1 Brand
11.6.2 Generic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Regofinil Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Regofinil Analysis and Forecast
12.1 Introduction
12.2 Latin America Regofinil Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Regofinil Market Size Forecast by Type
12.6.1 Brand
12.6.2 Generic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Regofinil Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Regofinil Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Regofinil Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Regofinil Market Size Forecast by Type
13.6.1 Brand
13.6.2 Generic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Regofinil Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Regofinil Market: Competitive Dashboard
14.2 Global Regofinil Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Natco
14.3.3 Bayer
